Fiocruz – AstraZeneca, COVID-19 Technological Order Agreement

Provision Language

1. Object and Territory

[…]

1.6.3 Within up to thirty (30) days from the present date, the Parties shall enter into Exhibit VI – Regulatory Activities Agreement, with the objective of, among others, disciplining the interaction of the Parties in relation to the Covid–19 Vaccine registration strategy with the National Agency Health Surveillance (“ANVISA”).